These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

257 related articles for article (PubMed ID: 23228159)

  • 1. Association between C-reactive protein and homocysteine with the subcomponents of metabolic syndrome in stable patients with bipolar disorder and schizophrenia.
    Vuksan-Cusa B; Sagud M; Jakovljevic M; Peles AM; Jaksic N; Mihaljevic S; Zivkovic M; Mikulic SK; Jevtovic S
    Nord J Psychiatry; 2013 Oct; 67(5):320-5. PubMed ID: 23228159
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metabolic syndrome and serum homocysteine in patients with bipolar disorder and schizophrenia treated with second generation antipsychotics.
    Vuksan-Ćusa B; Jakovljević M; Sagud M; Mihaljević Peleš A; Marčinko D; Topić R; Mihaljević S; Sertić J
    Psychiatry Res; 2011 Aug; 189(1):21-5. PubMed ID: 21216014
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metabolic syndrome and cardiovascular risk among institutionalized patients with schizophrenia receiving long term tertiary care.
    Seow LS; Chong SA; Wang P; Shafie S; Ong HL; Subramaniam M
    Compr Psychiatry; 2017 Apr; 74():196-203. PubMed ID: 28214752
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Levels of C-reactive protein (CRP) in patients with schizophrenia, unipolar depression and bipolar disorder.
    Wysokiński A; Margulska A; Strzelecki D; Kłoszewska I
    Nord J Psychiatry; 2015 Jul; 69(5):346-53. PubMed ID: 25495587
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metabolic syndrome and C-reactive protein in patients with depressive disorder on antidepressive medication.
    Stanojević A; Popović I; Nenadović M; Ravanić D; Paunović-Milosavljević G
    Srp Arh Celok Lek; 2013; 141(7-8):511-5. PubMed ID: 24073559
    [TBL] [Abstract][Full Text] [Related]  

  • 6. C-reactive protein and metabolic syndrome in patients with bipolar disorder compared to patients with schizophrenia.
    Vuksan-Cusa B; Sagud M; Jakovljević M
    Psychiatr Danub; 2010 Jun; 22(2):275-7. PubMed ID: 20562761
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of metabolic syndrome prevalence in patients with schizophrenia and bipolar I disorder.
    Nayerifard R; Bureng MA; Zahiroddin A; Namjoo M; Rajezi S
    Diabetes Metab Syndr; 2017 Nov; 11 Suppl 1():S411-S416. PubMed ID: 28927969
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum high-sensitivity C-reactive protein as a biomarker in patients with metabolic syndrome: evidence-based study with 7284 subjects.
    Mirhafez SR; Ebrahimi M; Saberi Karimian M; Avan A; Tayefi M; Heidari-Bakavoli A; Parizadeh MR; Moohebati M; Azarpazhooh MR; Esmaily H; Nematy M; Safarian M; Ferns GA; Ghayour-Mobarhan M
    Eur J Clin Nutr; 2016 Nov; 70(11):1298-1304. PubMed ID: 27460263
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cardiovascular risk factors during second generation antipsychotic treatment are associated with increased C-reactive protein.
    Dieset I; Hope S; Ueland T; Bjella T; Agartz I; Melle I; Aukrust P; Røssberg JI; Andreassen OA
    Schizophr Res; 2012 Sep; 140(1-3):169-74. PubMed ID: 22817875
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metabolic syndrome and adverse clinical outcomes in patients with bipolar disorder.
    Bai YM; Li CT; Tsai SJ; Tu PC; Chen MH; Su TP
    BMC Psychiatry; 2016 Dec; 16(1):448. PubMed ID: 27978821
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Equally increased risk for metabolic syndrome in patients with bipolar disorder and schizophrenia treated with second-generation antipsychotics.
    Correll CU; Frederickson AM; Kane JM; Manu P
    Bipolar Disord; 2008 Nov; 10(7):788-97. PubMed ID: 19032710
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Peripheral sub-inflammation is associated with antidepressant consumption in schizophrenia. Results from the multi-center FACE-SZ data set.
    Fond G; Godin O; Brunel L; Aouizerate B; Berna F; Bulzacka E; Capdevielle D; Chereau I; Dorey JM; Dubertret C; Dubreucq J; Faget C; Gabayet F; Le Strat Y; Micoulaud-Franchi JA; Misdrahi D; Rey R; Richieri R; Passerieux C; Schandrin A; Schürhoff F; Tronche AM; Urbach M; Vidalhet P; Llorca PM; Leboyer M;
    J Affect Disord; 2016 Feb; 191():209-15. PubMed ID: 26674214
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The metabolic syndrome is not associated with homocysteinemia: the Persian Gulf Healthy Heart Study.
    Nabipour I; Ebrahimi A; Jafari SM; Vahdat K; Assadi M; Movahed A; Moradhaseli F; Obeidi N; Sanjdideh Z
    J Endocrinol Invest; 2009 May; 32(5):406-10. PubMed ID: 19794288
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Hyperhomocysteinemia and schizophrenia: case control study].
    Mabrouk H; Douki W; Mechri A; Younes MK; Omezzine A; Bouslama A; Gaha L; Najjar MF
    Encephale; 2011 Sep; 37(4):308-13. PubMed ID: 21981892
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence and risk factors for metabolic syndrome in schizophrenia, schizoaffective, and bipolar disorder.
    Mohd Ahmed H; Abdel Aziz K; Al Ammari A; Galadari M; Alsaadi A; Alhassani A; Al Marzooqi F; AlAhbabi M; Alsheryani H; Bahayan M; Ahmed R; Alameri S; Stip E; Aly El-Gabry D
    Int J Psychiatry Clin Pract; 2024 Mar; 28(1):35-44. PubMed ID: 38329470
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Drawing up guidelines for the attendance of physical health of patients with severe mental illness].
    Saravane D; Feve B; Frances Y; Corruble E; Lancon C; Chanson P; Maison P; Terra JL; Azorin JM;
    Encephale; 2009 Sep; 35(4):330-9. PubMed ID: 19748369
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Association of C reactive protein levels with metabolic syndrome in adults: a population-based study].
    Bustos P; Rosas B; Román P; Villagrán J; Amigo H
    Rev Med Chil; 2016 Oct; 144(10):1239-1246. PubMed ID: 28074977
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Seasonal pattern in bipolar disorders and cardio-vascular risk factors: A study from the FACE-BD cohort.
    Geoffroy PA; Godin O; Mahee D; Henry C; Aubin V; Azorin JM; Bougerol T; Courtet P; Gard S; Kahn JP; Passerieux C; Leboyer M; Bellivier F; Etain B;
    Chronobiol Int; 2017; 34(7):845-854. PubMed ID: 28537802
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Homocysteine is the confounding factor of metabolic syndrome-confirmed by siMS score.
    Srećković B; Soldatovic I; Colak E; Mrdovic I; Sumarac-Dumanovic M; Janeski H; Janeski N; Gacic J; Dimitrijevic-Sreckovic V
    Drug Metab Pers Ther; 2018 Jun; 33(2):99-103. PubMed ID: 29624500
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A prospective, longitudinal study of metabolic syndrome in patients with bipolar disorder and schizophrenia.
    Malhotra N; Kulhara P; Chakrabarti S; Grover S
    J Affect Disord; 2013 Sep; 150(2):653-8. PubMed ID: 23608117
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.